ArTS Archivio della ricerca di Trieste

CESCUTTI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.657
AS - Asia 4.427
EU - Europa 4.346
SA - Sud America 525
AF - Africa 123
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 19.095
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.529
SG - Singapore 1.648
PL - Polonia 1.239
CN - Cina 1.147
IT - Italia 578
SE - Svezia 556
UA - Ucraina 498
HK - Hong Kong 422
VN - Vietnam 415
BR - Brasile 390
KR - Corea 279
FR - Francia 242
GB - Regno Unito 217
FI - Finlandia 205
DE - Germania 199
TR - Turchia 165
RU - Federazione Russa 135
BG - Bulgaria 112
IE - Irlanda 108
IN - India 98
CA - Canada 72
NL - Olanda 58
CH - Svizzera 53
AR - Argentina 49
JP - Giappone 41
ZA - Sudafrica 37
BD - Bangladesh 33
MX - Messico 30
BE - Belgio 27
IQ - Iraq 27
MA - Marocco 25
ID - Indonesia 22
EC - Ecuador 21
AT - Austria 19
ES - Italia 19
CL - Cile 18
PK - Pakistan 17
SN - Senegal 17
PH - Filippine 13
CO - Colombia 12
KE - Kenya 11
LT - Lituania 11
RO - Romania 11
SA - Arabia Saudita 10
VE - Venezuela 10
AU - Australia 9
EG - Egitto 9
HR - Croazia 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
JO - Giordania 8
NP - Nepal 8
TH - Thailandia 8
UZ - Uzbekistan 8
DZ - Algeria 6
HU - Ungheria 6
IL - Israele 6
JM - Giamaica 6
NO - Norvegia 6
PY - Paraguay 6
AZ - Azerbaigian 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
IR - Iran 5
KZ - Kazakistan 5
MY - Malesia 5
OM - Oman 5
PT - Portogallo 5
UY - Uruguay 5
DK - Danimarca 4
GE - Georgia 4
AL - Albania 3
CM - Camerun 3
CR - Costa Rica 3
EU - Europa 3
GT - Guatemala 3
LV - Lettonia 3
PA - Panama 3
RS - Serbia 3
SI - Slovenia 3
TN - Tunisia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CG - Congo 2
GA - Gabon 2
LU - Lussemburgo 2
MN - Mongolia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
UG - Uganda 2
BB - Barbados 1
BF - Burkina Faso 1
BS - Bahamas 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
Totale 19.079
Salva come PNG Salva come JPEG
Città #
Warsaw 1.129
Woodbridge 1.071
Singapore 988
Fairfield 903
Ashburn 805
Ann Arbor 765
Houston 591
Chandler 575
Wilmington 450
Jacksonville 438
San Jose 437
Hong Kong 415
Seattle 382
Cambridge 311
Hefei 301
Seoul 271
Beijing 264
Dallas 211
Trieste 206
Princeton 195
Boardman 187
Izmir 141
Chicago 131
Columbus 130
Ho Chi Minh City 121
Los Angeles 113
Sofia 110
Lauterbourg 108
Dublin 107
Hanoi 107
Zgierz 101
Dearborn 100
Council Bluffs 97
The Dalles 85
Moscow 80
Buffalo 75
Santa Clara 66
San Diego 59
Frankfurt am Main 49
London 46
Helsinki 45
São Paulo 45
Bern 44
Düsseldorf 41
New York 39
Milan 37
Falls Church 33
Shanghai 32
Toronto 31
Tokyo 29
Dong Ket 28
Munich 27
Brussels 25
Guangzhou 24
Phoenix 24
North Bergen 22
Nanjing 21
Kunming 19
Montreal 19
Nuremberg 19
Hangzhou 18
Norwalk 17
Dakar 16
Lappeenranta 16
Redondo Beach 16
Zhengzhou 16
Da Nang 15
Des Moines 15
Johannesburg 15
Bremen 14
New Delhi 14
Verona 14
Vienna 14
Casablanca 13
Haiphong 13
Jinan 13
Stockholm 13
Belo Horizonte 12
Chennai 12
Redmond 12
Washington 12
Nairobi 11
Orem 11
Rio de Janeiro 11
Rome 11
Tianjin 11
Amsterdam 10
Baghdad 10
Denver 10
Nanchang 10
Pune 10
Redwood City 10
San Francisco 10
Bexley 9
Charlotte 9
Chengdu 9
Florence 9
Fremont 9
Hyderabad 9
Paris 9
Totale 13.813
Salva come PNG Salva come JPEG
Nome #
Biofilms from Klebsiella pneumoniae: Matrix Polysaccharide Structure and Interactions with Antimicrobial Peptides 509
Antibacterial activity of Bac7(1-35) and BMAP-27 against biofilm-embedded A. baumannii 411
Tramesan, a novel polysaccharide from Trametes versicolor. Structural characterization and biological effects. 380
Multiple Techniques for Size Determination of Generalized Modules for Membrane Antigens from Salmonella typhimurium and Salmonella enteritidis 361
Structural analysis of the O-acetylated O-polysaccharide isolated from Salmonella Paratyphi A and used for vaccine preparation 354
Preclinical Antileukemia Activity of Tramesan: A Newly Identified Bioactive Fungal Metabolite 341
Structure of the capsular polysaccharide of the KPC-2-producing Klebsiella pneumoniae strain KK207-2 and assignment of the glycosyltransferases functions 312
The spent culture supernatant of Pseudomonas syringae contains azelaic acid 298
Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella 285
A novel highly charged exopolysaccharide produced by two strains of Stenotrophomonas maltophilia recovered from patients with cystic fibrosis 268
Biofilms produced by Burkholderia cenocepacia: Influence of media and solid supports on composition of matrix exopolysaccharides 267
Exopolysaccharides produced by a clinical strain of Burkholderia cepacia isolated from a cystic fibrosis patient 248
Conformational studies of the capsular polysaccharide produced by Neisseria meningitidis group A 248
Activity of antimicrobial peptides in the presence of polysaccharides produced by pulmonary pathogens. 245
Estratto fungino ad attività antitumorale 245
Influence of bacterial biofilm polysaccharide structure on interactions with antimicrobial peptides: A study on klebsiella pneumoniae 239
Complete structural characterization of the lipid A fraction of a clinical strain of B. cepacia genomovar I lipopolysaccharide 237
A conformational study of the Smith degradation product of the Klebsiella K40 capsular polysaccharide by 1D -NOESY and molecular mechanics calculations 233
Versatility of the Burkholderia cepacia Complex for the biosynthesis of exopolysaccharides: a comparative structural investigation 231
Macromolecular and solution properties of Cepacian: the exopolysaccharide produced by a strain of Burkholderia cepacia isolated from a cystic fibrosis patient. 224
Structure of the oligomers obtained by enzymatic hydrolysis of the glucomannan produced by the plant Amorphophallus konjac 214
Conformational properties of two exopolysaccharides produced by Inquilinus limosus, a cystic fibrosis lung pathogen 214
Structural determination of the polysaccharide isolated from biofilms produced by a clinical strain of Klebsiella pneumoniae 212
Bacterial Capsular Polysaccharides and Exopolysaccharides 208
Investigation of bacterial resistance to the immune system response: Cepacian depolymerisation by reactive oxygenspecies. 206
Conformational features of cepacian: the exopolysaccharide produced by clinical strains of Burkholderia cepacia 205
A novel rhamno-mannan exopolysaccharide isolated from biofilms of Burkholderia multivorans C1576 202
Genetic and structural elucidation of capsular polysaccharides from Streptococcus pneumoniae serotype 23A and 23B, and comparison to serotype 23F 202
Macromolecular properties of cepacian in water and in dimethylsulphoxide 196
Determination of the capsular polysaccharide structure of the Klebsiella pneumoniae ST512 representative strain KPB-1 and assignments of the glycosyltransferases functions 194
O-Acetyl location on Cepacian, the principal exopolysaccharide of Burkholderia cepacia complex bacteria 190
The structure of the exopolysaccharide of Pseudomonas fluorescens strain H13 189
New exopolysaccharides produced by Aureobasidium pullulans grown on glucosamine 187
Exopolysaccharides of the plant pathogens Pseudomonas corrugata and Ps. flavescens and the saprophyte Ps. chlororaphis 187
Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines. 184
Investigation on Sugar-Protein Connectivity in Salmonella O-Antigen Glycoconjugate Vaccines 184
Isolation and characterisation of the biological repeating unit of cepacian, the exopolysaccharide produced by Burkholderia cepacia complex bacteria 181
Structural investigation of the exopolysaccharide produced by Pseudomonas flavescens strain B62. Degradation by a fungal cellulase and isolation of the oligosaccharide repeating unit. 181
Structure of the exopolysaccharide produced by Enterobacter amnigenus. 180
Inhibition of cathelicidin activity by bacterial exopolysaccharides 180
Structure of a novel exopolysaccharide produced by Burkholderia vietnamiensis, a cystic fibrosis opportunistic pathogen 180
Interaction of antimicrobial peptides with bacterial polysaccharides from lung pathogens 175
Exopolysaccharides produced by Burkholderia cenocepacia recA lineages IIIA and IIIB. 174
Exopolysaccharides produced by Inquilinus limosus, a new pathogen of cystic fibrosis patients: novel structures with usual components 174
Studies on the primary structure of short polysaccharides using SEC MALDI mass spectroscopy. 173
The lipid A of Burkholderia multivorans C1576 smooth-type lipopolysaccharide and its pro-inflammatory activity in a cystic fibrosis airways model 173
The structure of the acidic exopolysaccharide produced by Pseudomonas "gingeri" strain Pf9 173
Structural investigation of the capsular polysaccharide produced by a novel Klebsiella serotype SK1. Location of O-acetyl substituents using NMR and MS techniques 172
Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex 171
Preliminary evaluation of an agar fraction obtained from Gracilaria verrucosa 171
First report of a lyase for cepacian, the polysaccharide produced by Burkholderia cepacia complex bacteria 170
Characterisation of a new cell wall teichoic acid produced by Listeria innocua ŽM39 and analysis of its biosynthesis genes 169
All-transglycolytic synthesis and characterisation of sialyl(alfa2-3)galactosyl(beta1-4)xylosyl-p-nitrophenyl(beta1-, an oligosaccharide derivative related to glycosaminoglycans biosynthesis 168
Divalent-cation interactions with oligogalacturonides. 165
Solution properties of the capsular polysaccharide produced by Klebsiella pneumoniae SK1 164
Screening the physical properties of novel Pseudomonas exopolysaccharides by HPSEC with multi-angle light scattering and viscosity detection 162
All-Transglycolytic Synthesis and Characterization of sialyl(α2–3)galactosyl(β1–4)xylosyl-p-nitrophenyl(β1–, an Oligosaccharide Derivative Related to Glycosaminoglycan Biosynthesis 161
Proteomic studies of the biofilm matrix including outer membrane vesicles of burkholderia multivorans c1576, a strain of clinical importance for cystic fibrosis 161
Exopolysaccharide-producing Lactic Acid Bacteria strains from traditional Thai fermented foods: isolation, identification and exopolysaccharide characterization. 160
Exopolysaccharides from Burkholderia cenocepacia inhibit neutrophil chemotaxis and scavenge reactive oxigen species 160
Fluorescence and NMR spectroscopy together with molecular simulations reveal amphiphilic characteristics of a Burkholderia biofilm exopolysaccharide 157
Structural Analysis of Fructans from Agave americana Grown in South Africa for Spirit Production 156
Identification of N-Acetylglucosamine and 4-O-[1-carboxyethyl]mannose in the exopolysaccharide from Cyanospira capsulata 156
On the specificity of a bacteriophage-borne endoglycanase for the native capsular polysaccharide produced by Klebsiella pneumoniae SK1 and its derived polymers 156
Solution properties of the capsular polysaccharide produced by Klebsiella pneumoniae K40 155
Burkholderia cenocepacia H111 produces a water-insoluble exopolysaccharide in biofilm: Structural determination and molecular modelling 153
Full Structural Characterisation of the Lipooligosaccharide of a Burkholderia pyrrocinia Clinical Isolate 152
Microbiological characterisation of Burkholderia cepacia isolates from cystic fibrosis patients: investigation of the exopolysaccharides produced 152
Structural study of the exopolysaccharide produced by a clinical isolate of Burkholderia cepacia. 151
Inhibition of antimicrobial peptides by exopolysaccharides of lung pathogens 148
Characterization of the Salmonella Typhimurium core oligosaccharide and its reducing end 3-deoxy-D-manno-oct-2-ulosonic acid used for conjugate vaccine production 147
Study of the inclusion complexes of aromatic molecules with cyclodextrins using ionspray mass spectrometry 144
Structural Study and Conformational Behavior of the Two DifferentLipopolysaccharide O-Antigens Produced by the Cystic Fibrosis Pathogen Burkholderia multivorans 142
Structural determination of the capsular polysaccharide produced by Klebsiella pneumoniae serotype K40. NMR studies of the oligosaccharide obtained upon depolymerisation of the polysaccharide with a bacteriophage-associated endoglycanase 141
Determination of the size and degree of acetyl substitution of oligosaccharides from Neisseria meningitidis group A by ionspray mass spectrometry 138
Lyophilized alginate-based microspheres containing Lactobacillus fermentum D12, an exopolysaccharides producer, contribute to the strain’s functionality in vitro 137
GMMA and glycoconjugate approaches compared in mice for the development of a vaccine against shigella flexneri serotype 6 136
Multifrequency STD NMR Unveils the Interactions of Antibiotics With Burkholderia multivorans Biofilm Exopolysaccharide 136
Influence of substituents on the solution conformation of the exopolysaccharide produced by Pseudomonas "gingeri" strain Pf9. 135
Structural determination of the acidic exopolysaccharide produced by a Pseudomonas sp. strain 1.15. 133
Identification of exopolysaccharides produced by fluorescent Pseudomonads associated with commercial mushroom (Agaricus bisporus) production 133
The polysaccharide extracted from the biofilm of Burkholderia multivorans strain C1576 binds hydrophobic species and exhibits a compact 3D-structure 133
Solution Properties of a Polysaccharide from the Cyanobacterium Cyanospira capsulata 132
Development and Application of a High-Throughput Method for the Purification and Analysis of Surface Carbohydrates from Klebsiella pneumoniae 129
The development and characterization of an E. coli O25B bioconjugate vaccine 127
Genetic and Structural Variation in the O-Antigen of Salmonella enterica Serovar Typhimurium Isolates Causing Bloodstream Infections in the Democratic Republic of the Congo 125
Ramachandran conformational energy maps for disaccharide linkages found in Burkholderia multivorans biofilm polysaccharides 123
Multi-technique microscopy investigation on bacterial biofilm matrices: a study on Klebsiella pneumoniae clinical strains 122
Effect of o-antigen chain length regulation on the immunogenicity of shigella and salmonella generalized modules for membrane antigens (GMMA) 122
Host-guest complex formation in cyclotrikis-(1-6)-[alfa-D-glucopyranosil-(1-4)-beta-D-glucopyranosil]. 120
Microbiological characterisation of Burkhlderia cepacia isolates from cystic fibrosis patients: investigation of the exopolysaccharides produced 119
Microscopy and modelling investigations on the morphology of the biofilm exopolysaccharide produced by Burkholderia multivorans strain C1576 114
Effect of methylation of beta-cyclodextrin on the formation of inclusion complexes with aromatic compounds. An ionspray mass spectrometry investigation 114
Periodate oxidation of cyclosophoraoses: a quantitative analysis of the reaction products by ionspray mass spectrometry 110
Molecular typing and exopolysaccharide biosynthesis of Burkholderia cepacia isolates from a portuguese cystic fibrosis center 109
Rapid generation of Shigella flexneri GMMA displaying natural or new and cross-reactive O-Antigens 108
Pellicle Biofilm Formation in Burkholderia cenocepacia J2315 is Epigenetically Regulated through WspH, a Hybrid Two-Component System Kinase-Response Regulator 108
Structural determination of the capsular polysaccharide produced by Klebsiella pneumoniae serotype K40 106
Modeling 1-Cyano-4-dimethylaminopyridine Tetrafluoroborate (CDAP) Chemistry to Design Glycoconjugate Vaccines with Desired Structural and Immunological Characteristics 105
Bacillus subtilis EpsA-O: A novel exopolysaccharide structure acting as an efficient adhesive in biofilms 102
Totale 18.494
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.806
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021382 0 0 0 0 0 0 0 0 0 171 55 156
2021/20221.144 37 125 94 72 22 81 54 41 149 137 85 247
2022/20231.709 158 208 120 262 170 273 26 152 236 11 74 19
2023/2024916 99 66 64 75 63 77 121 155 9 45 76 66
2024/20252.387 35 113 193 211 208 257 212 141 348 207 197 265
2025/20265.163 440 355 583 501 421 543 768 213 605 734 0 0
Totale 19.455